SYDNEY, AUSTRALIA, June 07, 2023 Immutep Limited , a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces. | June 7, 2023
Sydney, Australia, June 02, 2023 Immutep Limited, an Australian company , is pleased to announce the successful completion of an institutional placement and. | June 2, 2023
Immutep Successfully Completes Institutional Placement and Institutional Component of its Entitlement Offer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Media Release Appointment of Charles River Laboratories to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP761Forms a key step prior to. | May 29, 2023
Immutep (IMMP) Announces Publication of Abstracts streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.